ArticleClinical kidney journal2016

Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients.

Guillermo Rosa-Diez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.